Команда Inpharmatis приняла участие в конференции RAPS Euro Convergence 2024
May 10, 2024
April 23, 2024
Dr. Polina Dombure, Inpharmatis Group CEO, Participated in ISPE Europe Annual Conference 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, participated in the ISPE Europe Annual Conference held on 16-18 April 2024 in Lisbon. This Conference brings together pharmaceutical and biopharmaceutical professionals at all levels to discuss the industry’s most important topics.
During the conference dr. Polina Dombure had meetings with industry leaders, as well as current and prospective partners, for networking and knowledge exchange. The active participation of dr. Polina Dombure underscores Inpharmatis Group’s fostering collaborative partnerships and enhances its position in the EU and CIS pharmaceutical markets as a leader in GMP and regulatory fields.
For more information about Inpharmatis Group and its provided services, please contact us at info@inpharmatis.com.
Inpharmatis Team Participated in RAPS Euro Convergence 2024
May 10, 2024
Join us at RAPS Euro Convergence 2024 on 6-8 May in Berlin, Germany
April 26, 2024
Полина Домбуре, директор Inpharmatis, приняла участие в ISPE Europe Annual Conference 2024
April 23, 2024
Dr. Polina Dombure, Inpharmatis Group CEO, Participated in ISPE Europe Annual Conference 2024
April 23, 2024
Трудности регистрации медицинских изделий в ЕАЭС
March 26, 2024
Challenges of Medical Devices Registration in the EAEU
March 26, 2024
Новые поправки к Федеральному закону "Об обращении лекарственных средств" в России
March 13, 2024
New Amendments in Federal Law “On Circulation of Medicines” in Russia
March 13, 2024
В Грузии фармацевтические компании, не предоставившие сертификат GMP, столкнулись с новыми рисками
February 28, 2024